U.S. Advanced Diagnostic Imaging Equipment Market to $27.44B

Market Outlook

By 2035, the U.S. Advanced Diagnostic Imaging Equipment Market is expected to reach approximately USD 27.44 billion, expanding at a CAGR of 7.10% during the forecast period from 2026 to 2035. The market was valued at USD 13.82 billion in 2025, following historical expansion from USD 10.34 billion in 2021 to USD 12.83 billion in 2024. Values in this report are expressed in USD billions.

For the purpose of this report, advanced diagnostic imaging equipment includes computed tomography systems, magnetic resonance imaging systems, positron emission tomography and single-photon emission computed tomography equipment, hybrid molecular imaging platforms, advanced ultrasound systems, digital mammography and tomosynthesis equipment, high-end digital radiography, and advanced fluoroscopy systems. The market scope includes new equipment, major hardware upgrades, modality-integrated reconstruction software, detectors, coils, transducers, and related acquisition components. Imaging services, contrast media, radiopharmaceuticals, standalone PACS platforms, dental imaging, and used or refurbished systems are excluded.

The U.S. market is entering a replacement and capability-upgrade cycle rather than a simple expansion cycle. Hospitals are replacing aging scanners while simultaneously moving toward wider detector coverage, higher magnetic-field strength, spectral imaging, photon-counting detection, faster reconstruction, lower radiation exposure, helium-efficient magnets, automated positioning, and AI-supported image acquisition. This raises the average value of each installed system and creates a larger aftermarket for software, detector, coil, workstation, and workflow upgrades.

Demand is supported by the scale of the U.S. healthcare delivery network. The country has approximately 6,100 hospitals, more than 907,000 staffed beds, and nearly 35.66 million annual hospital admissions. Around 70% of community hospitals are affiliated with health systems, increasing the importance of enterprise procurement agreements, multi-site equipment standardization, cybersecurity compliance, fleet analytics, and vendor-managed service programs.

Clinical demand is also expanding. The U.S. population aged 65 and older reached approximately 61.2 million in 2024. Older adults require disproportionately high volumes of CT, MRI, PET, mammography, ultrasound, and fluoroscopic examinations because of cancer, cardiovascular disease, neurological disorders, musculoskeletal degeneration, pulmonary disease, and multimorbidity. The latest consolidated national cancer dataset reported more than 1.85 million new cases in one year, creating a substantial recurring requirement for detection, staging, treatment planning, response assessment, and surveillance imaging.

The historical market advanced from USD 10.34 billion in 2021 to USD 11.08 billion in 2022, USD 11.92 billion in 2023, and USD 12.83 billion in 2024. Recovery in hospital capital spending, normalization of elective diagnostic volumes, expansion of outpatient imaging centers, and demand for more efficient scanners supported this progression. In 2025, market value reached USD 13.82 billion as major health systems accelerated replacement of older CT, MRI, molecular imaging, mammography, and ultrasound fleets.

Growth through 2035 will be led by photon-counting CT, high-field and helium-efficient MRI, total-body and digital PET, compact SPECT/CT, advanced breast imaging, AI-enabled ultrasound, mobile imaging, remote scanning, and software-defined equipment upgrades. The market will also benefit from hospital demand for scanners that can increase daily examination capacity without requiring proportional growth in radiologist or technologist staffing.

Introduction

According to the U.S. Advanced Diagnostic Imaging Equipment Market Report, diagnostic imaging has become a strategic clinical infrastructure category rather than a supporting hospital function. Imaging influences emergency triage, cancer diagnosis, surgical planning, cardiovascular intervention, neurological assessment, orthopedic care, women’s health, and chronic disease monitoring. The performance and availability of imaging equipment can therefore affect hospital referral capture, emergency department throughput, inpatient length of stay, procedural scheduling, and specialist productivity.

The economic value of advanced imaging equipment is increasingly determined by workflow performance. U.S. buyers are evaluating scanners based on examinations completed per day, protocol consistency, patient setup time, repeat-scan rates, energy consumption, radiation exposure, technologist burden, service uptime, software-upgrade flexibility, and interoperability with enterprise imaging systems. Acquisition price remains important, but it is no longer an adequate measure of system value.

This change is especially relevant because the radiology workforce is under pressure. Imaging volumes are rising while many hospitals, independent diagnostic testing facilities, and radiology practices report difficulty recruiting radiologists, MRI technologists, CT technologists, sonographers, and nuclear medicine personnel. Equipment that automates patient positioning, protocol selection, scan planning, image reconstruction, quality control, and preliminary workflow prioritization can improve effective capacity without eliminating the need for trained clinical oversight.

The market is also becoming more concentrated at the purchasing level. Large integrated delivery networks are standardizing imaging fleets across academic hospitals, community hospitals, outpatient departments, urgent-care locations, and freestanding centers. Standardization can reduce training requirements, simplify service contracts, improve data consistency, and create leverage in enterprise negotiations. It also raises the commercial importance of long-term relationships, installed-base compatibility, remote support, cybersecurity, and guaranteed uptime.

Advanced diagnostic imaging equipment is not a uniform capital category. CT purchasing is influenced by detector capability, temporal resolution, dose performance, cardiac imaging requirements, and emergency throughput. MRI investment is affected by field strength, bore design, helium dependency, coil architecture, siting requirements, and scan duration. PET and SPECT economics depend on tracer access, detector sensitivity, examination time, and oncology or cardiology referral volumes. Ultrasound purchasing is more decentralized and depends heavily on portability, transducer breadth, operator usability, and specialty workflow.

From 2026 to 2035, competitive advantage will increasingly shift from individual scanners toward connected imaging ecosystems. Vendors capable of combining equipment, embedded AI, protocol management, remote operations, enterprise fleet monitoring, cybersecurity, image reconstruction, and lifecycle service will be better positioned than manufacturers competing primarily through hardware specifications.

Key Market Drivers: What Is Fueling the U.S. Advanced Diagnostic Imaging Equipment Market Boom?

The first major driver is the expanding disease burden that requires imaging across the patient journey. Cancer patients may undergo screening, diagnostic confirmation, staging, biopsy guidance, treatment planning, response assessment, and long-term surveillance. Cardiovascular patients increasingly require coronary CT angiography, cardiac MRI, echocardiography, nuclear perfusion imaging, and vascular ultrasound. Neurological patients depend on CT and MRI for stroke, dementia, epilepsy, multiple sclerosis, trauma, and neuro-oncology evaluation.

Cancer represents one of the strongest demand foundations. More than 288,000 new female breast cancers, approximately 228,000 lung cancers, more than 266,000 prostate cancers, and around 156,000 colorectal cancers were reported in the latest disease-specific U.S. datasets. These indications support demand for mammography, breast tomosynthesis, CT, PET/CT, MRI, ultrasound, and image-guided diagnostic equipment. As precision oncology expands, imaging is also becoming more closely linked to biomarker selection, radiotherapy planning, and therapy-response measurement.

A second driver is the rapid aging of the U.S. population. Adults aged 65 and older are more likely to require repeated imaging because of cancer, stroke, coronary disease, osteoarthritis, spinal disorders, fractures, cognitive decline, and chronic pulmonary conditions. Aging also creates demand for wider-bore MRI, faster protocols, motion correction, lower-dose CT, and systems designed for patients with limited mobility or multiple comorbidities.

A third driver is the replacement of aging installed equipment. Many U.S. hospitals continue to operate imaging systems beyond the point at which newer platforms offer material gains in throughput, dose efficiency, image quality, energy use, and software compatibility. Replacement decisions are frequently delayed because of capital constraints, construction requirements, and competing hospital priorities. When replacement occurs, however, buyers increasingly move to higher-specification systems rather than purchasing equivalent conventional equipment.

A fourth driver is the evolution of CT technology. Spectral CT, dual-energy CT, wide-area detector systems, deep-learning reconstruction, automated cardiac imaging, and photon-counting detectors are raising the clinical and economic value of the modality. Photon-counting CT can generate higher spatial resolution and spectral information while supporting dose and contrast-efficiency objectives. The technology is initially concentrated in academic and high-acuity hospitals, but broader product availability is expected to extend adoption into large community systems.

A fifth driver is MRI workflow modernization. MRI has historically faced limitations related to scan duration, patient anxiety, siting complexity, helium dependency, and specialist staffing. Newer systems address these barriers through compressed sensing, deep-learning reconstruction, automated planning, wider bores, lighter magnets, reduced-helium designs, improved coils, and faster specialty protocols. The ability to complete more examinations per installed magnet is strategically valuable in markets where MRI appointment backlogs can extend for days or weeks.

A sixth driver is the expansion of molecular imaging. PET/CT demand is increasing in oncology, cardiology, and neurology, supported by more targeted radiotracers and broader clinical use of prostate-specific membrane antigen, amyloid, tau, cardiac, and oncology imaging agents. Higher-sensitivity digital detectors and total-body configurations can reduce acquisition time, support lower administered activity, or provide greater anatomical coverage. SPECT/CT remains important in cardiac perfusion, bone imaging, infection, endocrinology, and selected oncology applications.

A seventh driver is outpatient migration. Freestanding imaging centers, hospital outpatient departments, specialty practices, and ambulatory facilities are investing in equipment that combines premium image quality with lower operating complexity. Outpatient operators typically place greater emphasis on examination throughput, scheduling flexibility, payer authorization, patient convenience, and total installed cost. This favors wide-bore MRI, efficient CT, advanced ultrasound, digital mammography, and compact molecular imaging systems.

An eighth driver is the need to manage workforce shortages. Automated positioning, intelligent protocol selection, camera-based patient setup, remote scanning, centralized command centers, AI reconstruction, and automated image-quality checks can reduce variability and allow experienced personnel to support multiple locations. Remote operations will not remove the need for on-site patient safety and clinical staff, but they can make specialist expertise available across broader imaging networks.

A ninth driver is the scale of radiology AI. By the end of 2025, approximately 1,451 AI-enabled medical devices had received U.S. authorization, with radiology accounting for roughly 76% of the total. This density reflects the suitability of imaging data for automated detection, segmentation, quantification, reconstruction, triage, and quality assurance. AI is increasingly becoming an embedded equipment feature rather than a separately purchased application.

A tenth driver is hospital consolidation. System-affiliated hospitals can purchase equipment through multi-year contracts covering scanners, software, maintenance, consumables, remote support, and upgrade pathways. This purchasing model benefits vendors with broad modality portfolios and national service networks. It also creates opportunities for emerging suppliers capable of offering materially lower lifecycle cost or differentiated performance.

Capital procurement economics will remain a decisive factor. High-end imaging systems may require substantial room preparation, shielding, electrical infrastructure, cooling, installation, staff training, and service commitments. Buyers therefore evaluate the full installed and operating cost rather than the scanner price alone. Equipment that avoids major construction, lowers helium or energy dependency, reduces examination time, or supports software-based capability upgrades can achieve stronger investment approval.

Reimbursement conditions provide both support and restraint. Medicare and commercial payers continue to scrutinize imaging utilization, site of service, medical necessity, prior authorization, and payment differentials. The federal Appropriate Use Criteria program for advanced imaging has been paused and its implementing regulations rescinded while the program is reevaluated. Nevertheless, health systems continue to invest in clinical decision support, utilization management, and documentation because inappropriate imaging can increase denial risk and reduce equipment productivity.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Photon-counting CT is one of the most strategically important innovations in the market. Unlike conventional energy-integrating detector systems, photon-counting detectors directly register individual X-ray photons and can capture energy-specific information. The technology can improve spatial resolution, spectral characterization, artifact reduction, and dose efficiency. Commercial adoption remains concentrated in institutions that can support premium capital investment and advanced clinical programs, but competition is broadening.

In 2025, an expanded class of photon-counting CT systems received U.S. regulatory clearance, including dual-source and single-source configurations. A first U.S. installation of one newly introduced system followed later in the year. By that period, more than two million patients had reportedly been scanned worldwide using commercially deployed photon-counting CT technology. These milestones indicate that the category is moving beyond early research use toward repeatable clinical procurement.

MRI innovation is focused on speed, access, sustainability, and advanced tissue characterization. Deep-learning reconstruction can improve image quality or shorten acquisition time, while automated planning reduces operator dependence. Helium-efficient and sealed-magnet platforms lower exposure to helium supply risks and can simplify siting. By 2024, one major manufacturer had installed more than 1,100 helium-minimizing MRI systems globally, increasing to more than 1,500 installations by early 2025.

Ultra-high-field MRI is also moving closer to broader clinical use. A whole-body 5T MRI system received U.S. clearance in 2024, extending ultra-high-field capability beyond conventional research-oriented configurations. The commercial significance will depend on protocol development, reimbursement, siting economics, evidence generation, and the ability to translate higher field strength into consistent clinical benefit.

Molecular imaging manufacturers are increasing detector sensitivity, axial coverage, time-of-flight performance, and quantitative accuracy. Total-body PET/CT is particularly relevant for dynamic imaging, low-dose studies, pediatric applications, systemic disease assessment, and translational research. Wider clinical adoption will depend on capital cost, tracer economics, throughput, reimbursement, and the strength of evidence supporting new applications.

Advanced ultrasound is evolving through AI-guided acquisition, automated measurements, elastography, contrast-enhanced imaging, 3D and 4D visualization, and compact high-performance platforms. Ultrasound benefits from a large installed base and can be deployed in hospitals, clinics, emergency departments, physician offices, and mobile settings. Manufacturers are attempting to reduce operator variability by embedding anatomical recognition, view guidance, and automated quantification.

Breast imaging continues to advance through digital breast tomosynthesis, contrast-enhanced mammography, automated breast ultrasound, AI-assisted detection, synthetic 2D image generation, and deep-learning reconstruction. Procurement is affected by screening volumes, breast-density legislation, state-level access, patient comfort, recall rates, and integration with breast MRI and ultrasound pathways.

Portable and mobile imaging equipment is another important innovation category. Mobile CT, compact MRI, handheld ultrasound, mobile digital radiography, and trailer-based equipment can support stroke programs, intensive care, emergency care, rural access, temporary capacity, and construction-related downtime. These systems are not expected to replace high-end fixed scanners, but they can expand imaging availability and reduce patient transport.

The software-defined scanner is becoming a major commercial model. Vendors are designing equipment that can receive reconstruction, workflow, protocol, quantification, and clinical capability upgrades during the asset life. This protects health systems from rapid obsolescence and creates recurring revenue for manufacturers. It also changes procurement evaluation because buyers must assess future software access, licensing terms, interoperability, and cybersecurity support.

Remote operations are moving from pilot programs toward organized imaging networks. Experienced technologists can support protocol setup and scanning workflows across multiple facilities using centralized command infrastructure. This is especially relevant for rural hospitals and community sites that cannot maintain deep staffing across every modality and shift. Successful implementation requires defined responsibilities, secure connectivity, local emergency coverage, and consistent credentialing.

Manufacturers are also raising the bar through evidence generation. Premium equipment is increasingly supported by multicenter validation, dose studies, workflow assessments, health-economic models, and real-world data. Hospitals want to know whether a system can reduce repeat examinations, shorten scan time, increase daily capacity, avoid unnecessary follow-up, improve diagnostic confidence, or lower the total cost of care.

Segmentation Insights

The U.S. Advanced Diagnostic Imaging Equipment Market is segmented on the basis of modality, installation type, application, end user, and region.

By Modality

Computed Tomography Systems

Computed tomography represented the largest modality segment in 2025, accounting for an estimated USD 3.46 billion. The segment includes conventional multidetector CT, wide-area detector CT, spectral and dual-energy CT, cardiac CT, photon-counting CT, mobile CT, and specialty configurations.

CT demand is supported by emergency medicine, trauma, oncology, pulmonary imaging, cardiovascular assessment, neurology, abdominal imaging, and image-guided procedures. Its speed and broad clinical utility make it one of the most intensively used imaging modalities in U.S. hospitals. Replacement decisions increasingly favor lower-dose reconstruction, automated positioning, cardiac capability, spectral imaging, and workflow tools that reduce examination variability.

Photon-counting CT will generate the strongest premium growth within the segment. Initial installations will remain concentrated in academic centers and major referral hospitals, but more product configurations and competitive entries should gradually expand the addressable customer base. Conventional multidetector CT will continue to account for most unit installations because of its lower capital cost and established clinical utility.

Magnetic Resonance Imaging Systems

MRI equipment generated an estimated USD 3.18 billion in 2025. The segment includes 1.5T, 3T, 5T and research-oriented ultra-high-field systems, open MRI, extremity MRI, wide-bore scanners, mobile MRI, coils, and major reconstruction upgrades.

The U.S. has strong demand for neuroimaging, musculoskeletal imaging, breast MRI, cardiac MRI, prostate imaging, abdominal imaging, pediatric care, and oncology. The segment benefits from the absence of ionizing radiation but faces barriers including examination duration, patient tolerance, magnet siting, energy use, and staffing requirements.

Growth will be driven by faster acquisition, AI reconstruction, automated planning, helium-efficient magnets, lightweight siting designs, advanced diffusion, quantitative imaging, cardiac protocols, and wider bores. Facilities with long MRI backlogs can generate a clear economic return from technology that increases daily examination capacity.

Molecular Imaging Systems

Molecular imaging equipment accounted for approximately USD 2.21 billion in 2025. The segment includes PET, PET/CT, PET/MRI, SPECT, SPECT/CT, cardiac nuclear imaging systems, digital detectors, and related acquisition workstations.

Oncology represents the largest demand base, but neurological and cardiovascular applications are gaining strategic importance. PET/CT is benefiting from targeted prostate cancer imaging, amyloid and tau imaging, theranostics, and broader precision-oncology use. Digital PET and total-body systems can support faster acquisition, improved sensitivity, dynamic imaging, and lower-dose protocols.

SPECT and SPECT/CT remain important because of their installed base, lower equipment cost, and utility across cardiology, bone imaging, endocrinology, infection, and selected oncology procedures. Compact cardiac systems and CZT detector technologies provide opportunities for specialty practices and outpatient providers.

Advanced Ultrasound Systems

Advanced ultrasound generated an estimated USD 2.35 billion in 2025. This segment includes high-end cart-based ultrasound, 3D and 4D systems, elastography, contrast-enhanced ultrasound, automated breast ultrasound, premium cardiovascular systems, and AI-enabled portable platforms.

Ultrasound is used across radiology, cardiology, obstetrics, gynecology, vascular medicine, emergency care, anesthesia, oncology, hepatology, and musculoskeletal care. Its lower capital requirement and lack of ionizing radiation support broad deployment. However, image quality and diagnostic reliability remain dependent on operator skill.

AI-guided acquisition, automated measurements, improved transducers, miniaturization, wireless connectivity, and specialty-specific workflow packages will support growth. Portable systems will expand access, while high-end platforms will remain essential for complex cardiovascular, maternal-fetal, abdominal, and interventional applications.

Advanced X-Ray, Fluoroscopy and Breast Imaging Systems

Advanced X-ray, fluoroscopy, and breast imaging equipment accounted for approximately USD 2.62 billion in 2025. The segment includes premium digital radiography, advanced fluoroscopy, digital subtraction angiography used for diagnostic workflows, digital mammography, breast tomosynthesis, contrast-enhanced mammography, and mobile digital radiography.

Digital mammography and tomosynthesis represent the most innovation-intensive components. Demand is supported by recurring screening requirements, breast-density evaluation, diagnostic follow-up, and integration with ultrasound and MRI. AI-assisted interpretation and reconstruction are becoming standard competitive features.

Advanced radiography and fluoroscopy remain essential across emergency, orthopedic, gastrointestinal, urological, pediatric, and procedural imaging. Growth is driven less by new modality creation and more by detector replacement, dose optimization, automation, mobile deployment, and integration with hospital imaging networks.

By Installation Type

Fixed Room-Based Imaging Equipment

Fixed room-based systems accounted for approximately 74.5% of market revenue in 2025. This category includes most high-end CT, MRI, PET/CT, SPECT/CT, fluoroscopy, mammography, and premium ultrasound installations.

These systems offer the highest clinical performance but require significant site planning. Procurement may include shielding, structural modification, electrical upgrades, cooling, magnet safety, radiation-safety review, and workflow redesign. Hospitals commonly evaluate a fixed installation over a seven- to twelve-year operating horizon, depending on modality, service intensity, and upgrade strategy.

Mobile Cart-Based Equipment

Mobile cart-based equipment includes premium ultrasound, mobile digital radiography, compact fluoroscopy, and selected nuclear imaging systems. It represented approximately 10.0% of the market in 2025.

Demand is supported by intensive care, emergency departments, operating rooms, inpatient floors, and facilities seeking to reduce patient transportation. Mobile equipment procurement emphasizes maneuverability, battery performance, infection control, wireless connectivity, and rapid image transfer.

Portable and Handheld Systems

Portable and handheld equipment represented approximately 6.5% of market value in 2025. The segment is dominated by ultrasound but also includes compact digital radiography and emerging low-field MRI configurations.

Portable ultrasound is expanding beyond traditional imaging departments into emergency medicine, critical care, anesthesia, obstetrics, primary care, and home-based assessment. Premium growth will depend on image quality, AI guidance, reimbursement pathways, data integration, and clinician training.

Intraoperative and Point-of-Procedure Imaging

Intraoperative and point-of-procedure systems accounted for approximately 5.0% of 2025 market revenue. The segment includes intraoperative CT, MRI, advanced C-arms, mobile 3D imaging, and imaging platforms used during surgery or intervention.

Demand is supported by spine, neurosurgery, orthopedics, trauma, vascular procedures, and complex oncology care. Buyers evaluate these systems based on navigation compatibility, room utilization, radiation control, image quality, and their ability to reduce revision procedures or confirm technical success before the patient leaves the operating room.

Trailer-Based and Shared-Service Imaging

Trailer-based and shared-service systems represented approximately 4.0% of the market in 2025. Mobile MRI, CT, PET/CT, and mammography fleets provide temporary capacity, rural access, construction support, and lower-volume facilities with access to equipment that may not be economically viable as a permanent installation.

This model is attractive to hospitals facing delayed capital approval or facility renovation. Long-term growth will depend on reimbursement, routing economics, equipment uptime, regulatory compliance, and the ability to maintain consistent patient experience across locations.

By Application

Oncology

Oncology was the largest application segment in 2025, accounting for approximately 28% of equipment demand. CT, MRI, PET/CT, mammography, ultrasound, and fluoroscopy are used throughout the cancer pathway.

Growth is being driven by lung cancer screening, breast screening, prostate imaging, molecular imaging, radiotherapy planning, image-guided biopsy, treatment-response assessment, and surveillance. Oncology programs frequently justify premium equipment because advanced imaging supports multiple high-value service lines.

Cardiology and Vascular Imaging

Cardiology and vascular applications represented approximately 20% of the market. Demand includes coronary CT angiography, cardiac MRI, echocardiography, nuclear perfusion imaging, vascular ultrasound, and fluoroscopic evaluation.

Cardiac CT is benefiting from faster gantry rotation, improved temporal resolution, spectral imaging, automated calcium scoring, and lower-dose protocols. Cardiac MRI continues to expand in tissue characterization, congenital disease, cardiomyopathy, viability, and inflammation. Cardiovascular service lines are strategically important to hospitals, supporting capital investment in high-performance equipment.

Neurology

Neurology accounted for approximately 18% of 2025 equipment demand. CT and MRI are central to stroke, trauma, brain tumors, dementia, epilepsy, multiple sclerosis, spine disease, and neurodegenerative disorders. PET is gaining relevance through amyloid and tau imaging.

The stroke pathway creates strong demand for rapid CT, CT angiography, CT perfusion, and MRI. Hospitals seeking comprehensive stroke-center designation or faster emergency triage may prioritize equipment with automated reconstruction, perfusion analysis, and remote-reading integration.

Musculoskeletal and Trauma Imaging

Musculoskeletal and trauma applications represented approximately 15% of the market. MRI, CT, digital radiography, ultrasound, and weight-bearing CT support fracture assessment, sports medicine, arthritis, spine disease, joint disorders, and surgical planning.

Outpatient orthopedic networks and imaging centers are important buyers of MRI and digital radiography. Growth is supported by an aging population, high sports participation, obesity-related joint disease, and demand for faster musculoskeletal MRI protocols.

Women’s Health and Other Applications

Women’s health and other applications accounted for the remaining 19% of market demand. This category includes breast imaging, obstetric and gynecological ultrasound, abdominal imaging, pulmonary care, gastrointestinal disease, urology, pediatrics, and general diagnostic use.

Breast imaging is the largest component, supported by screening mammography, tomosynthesis, ultrasound, contrast-enhanced mammography, and MRI. Obstetric ultrasound remains a high-volume category, while abdominal CT, MRI, and ultrasound support broad recurring utilization across hospital and outpatient settings.

By End User

Hospitals and Integrated Delivery Networks

Hospitals and integrated delivery networks accounted for approximately 59% of market revenue in 2025. They purchase the majority of high-end CT, MRI, PET/CT, SPECT/CT, fluoroscopy, and intraoperative imaging systems.

Large systems increasingly negotiate enterprise agreements covering multiple modalities and sites. Procurement decisions involve radiology, finance, information technology, cybersecurity, biomedical engineering, facilities management, supply chain, and value-analysis committees. Vendors must demonstrate clinical performance, service reliability, interoperability, and measurable operating value.

Independent Diagnostic Imaging Centers

Independent and physician-affiliated diagnostic imaging centers represented approximately 19% of the market. These operators emphasize utilization, scheduling, payer mix, patient access, and rapid return on invested capital.

MRI, CT, mammography, ultrasound, and PET/CT are the most important categories. Imaging centers frequently compete through convenient locations, evening or weekend hours, faster appointment availability, and lower prices than hospital outpatient departments.

Academic Medical Centers and Research Institutions

Academic medical centers accounted for approximately 9% of the market. Although their unit volumes are lower than the combined community-hospital base, they purchase a disproportionate share of premium, research-capable, photon-counting, ultra-high-field, total-body, and advanced molecular imaging systems.

These institutions influence national adoption by producing clinical evidence, training specialists, establishing protocols, and hosting early commercial installations. Their purchasing decisions can materially affect manufacturer credibility.

Specialty Clinics and Ambulatory Facilities

Specialty clinics and ambulatory facilities represented approximately 8% of market revenue. Buyers include cardiology groups, orthopedic practices, women’s health centers, oncology centers, vascular clinics, urgent-care networks, and ambulatory surgery centers.

Demand is strongest for ultrasound, compact nuclear cardiology systems, extremity imaging, digital radiography, mammography, and selected CT or MRI configurations. Equipment must fit lower-volume economics and often requires simplified operation.

Mobile, Rural and Community Imaging Providers

Mobile and community imaging providers accounted for approximately 5% of the market. Their strategic importance is greater than their current revenue share because they address access gaps in rural and underserved areas.

Portable ultrasound, mobile radiography, trailer-based MRI and CT, compact scanners, and remote operations can extend advanced diagnostics to locations that cannot support full-time specialists. Federal and state access initiatives may strengthen this segment over the forecast period.

Regional Insights: Where the Market Is Growing Fastest

The U.S. Advanced Diagnostic Imaging Equipment Market is geographically segmented into the South, West, Northeast, and Midwest. Regional differences are shaped by population growth, age distribution, hospital concentration, cancer burden, specialist availability, outpatient imaging density, academic research infrastructure, and health-system capital capacity.

The South was the largest regional market in 2025, while the West is expected to record the fastest growth through 2035. The Northeast remains the most concentrated market for high-acuity and research-oriented installations. The Midwest provides a substantial replacement base supported by established hospital systems and medical technology expertise.

South

The South generated an estimated USD 4.70 billion in 2025 and is projected to reach approximately USD 9.54 billion by 2035. The regional market includes Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, Washington, D.C., West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas.

Its leadership is supported by large population centers, rapid migration into major metropolitan areas, a growing older population, high chronic disease burden, and substantial hospital construction. The region combines major academic institutions with a large base of community hospitals, outpatient imaging centers, and rural facilities.

Texas represented the largest Southern state market, valued at approximately USD 1.25 billion in 2025. Houston, Dallas-Fort Worth, Austin, and San Antonio support high-volume hospital systems, cancer centers, trauma programs, and cardiovascular networks. Texas is strategically important for CT, MRI, molecular imaging, women’s health, and mobile imaging. Its geographic scale also creates demand for remote operations and distributed service coverage.

Florida represented approximately USD 1.05 billion. The state’s large older population supports demand for oncology imaging, cardiac imaging, neurological assessment, musculoskeletal MRI, and breast diagnostics. Large health systems and outpatient networks continue to expand across Miami, Tampa, Orlando, Jacksonville, and Southwest Florida.

North Carolina, Georgia, Tennessee, and Virginia are high-growth equipment markets. North Carolina combines population expansion with research-oriented health systems and a strong biotechnology presence. Georgia benefits from Atlanta’s regional referral role. Tennessee has major healthcare operators and established hospital procurement expertise. Virginia combines affluent metropolitan markets with large military, federal, and academic healthcare networks.

Maryland and Washington, D.C. are smaller by population but strategically influential because of major research institutions, federal healthcare activity, oncology programs, and advanced academic medicine. These markets are attractive for premium MRI, molecular imaging, neurological imaging, and clinical research systems.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia, and Oklahoma have significant disease burden but more uneven access to advanced equipment. Major referral centers will continue purchasing premium systems, while rural areas are likely to depend more heavily on mobile, portable, shared-service, and remote-supported imaging models.

The South will remain the largest market through 2035. Growth will be driven by hospital expansion, outpatient imaging development, cancer-care capacity, aging demographics, and replacement of older equipment across large multi-state systems.

West

The West represented approximately USD 3.39 billion in 2025 and is expected to reach USD 7.24 billion by 2035, recording the fastest regional CAGR. The region includes Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, Wyoming, Alaska, California, Hawaii, Oregon, and Washington.

California was the largest Western market and the largest individual state opportunity in the country, generating approximately USD 1.90 billion in 2025. Its leadership is supported by a large population, extensive health-system infrastructure, academic medical centers, oncology programs, outpatient imaging networks, and a strong technology ecosystem.

California is particularly important for AI-enabled imaging, molecular imaging, advanced MRI, photon-counting CT, breast imaging, and software-defined equipment. Health systems in Los Angeles, San Diego, the San Francisco Bay Area, Sacramento, and Orange County often serve as evaluation sites for new technology.

Arizona and Nevada are benefiting from population growth and aging demographics. Both states are expanding hospital and outpatient capacity, supporting demand for MRI, CT, cardiology imaging, and oncology equipment. Arizona generated an estimated USD 0.34 billion in 2025 and is expected to outperform the national growth rate.

Washington and Oregon have strong integrated delivery networks and high adoption of connected-care technologies. Washington represented approximately USD 0.33 billion in 2025. Major provider systems are investing in enterprise imaging, advanced reconstruction, neurological imaging, and oncology capacity.

Colorado and Utah combine population growth with research-oriented health systems, specialty care expansion, and comparatively strong digital-health adoption. Colorado is an important market for sports medicine, oncology, cardiac imaging, and outpatient MRI. Utah benefits from centralized health systems capable of deploying standardized imaging platforms across broad geographic areas.

Idaho, Montana, Wyoming, Alaska, New Mexico, and Hawaii have smaller absolute markets but substantial access requirements. Long travel distances and limited specialist availability create opportunities for portable ultrasound, mobile radiography, trailer-based CT and MRI, compact systems, and remote scanning.

The West will gain market share through 2035 as equipment becomes more connected, mobile, software-defined, and resource-efficient. The region will remain a major early-adoption market for AI, low-helium MRI, remote operations, and advanced CT.

Northeast

The Northeast generated approximately USD 3.18 billion in 2025 and is projected to reach USD 6.05 billion by 2035. The region includes Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, and Pennsylvania.

The Northeast has the highest concentration of academic medical centers, specialty hospitals, research institutions, and advanced radiology programs. Its population growth is slower than that of the South and West, but its equipment mix is weighted toward premium systems and complex clinical applications.

New York was the largest Northeastern state market, valued at approximately USD 0.92 billion in 2025. New York City supports a dense network of academic institutions, cancer centers, community hospitals, and outpatient providers. Upstate New York creates a separate requirement for regional networks, mobile access, and multi-site fleet management.

Pennsylvania generated approximately USD 0.62 billion and has major academic and community health systems in Philadelphia, Pittsburgh, and central Pennsylvania. The state supports demand for oncology imaging, emergency CT, advanced MRI, cardiac imaging, and rural access solutions.

Massachusetts represented approximately USD 0.44 billion. Despite its smaller population, the state has outsized influence because of its academic hospitals, biotechnology ecosystem, imaging research, and early adoption of premium equipment. It is an important market for ultra-high-field MRI, molecular imaging, AI validation, and clinical trials.

New Jersey and Connecticut have high hospital and outpatient imaging density, affluent payer markets, and strong connections to the New York metropolitan healthcare ecosystem. New Jersey generated an estimated USD 0.41 billion in 2025.

Maine, Vermont, New Hampshire, and Rhode Island are smaller markets. Their opportunities are concentrated in replacement demand, regional referral centers, mobile services, and equipment that can operate efficiently at moderate examination volumes.

Procurement in the Northeast is rigorous and evidence-driven. Hospitals frequently require detailed validation of clinical utility, service performance, cybersecurity, integration, and return on capital. The region will remain attractive for premium technology even though its overall CAGR is expected to remain below that of the West and South.

Midwest

The Midwest represented approximately USD 2.55 billion in 2025 and is projected to reach USD 4.61 billion by 2035. The region includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota.

Demand is supported by established hospital systems, large community-provider networks, chronic disease burden, academic centers, and a substantial installed base approaching replacement. The region has a strong tradition in radiology, cardiology, oncology, and medical technology manufacturing.

Illinois generated approximately USD 0.52 billion in 2025. Chicago’s academic and community hospital network supports high-end CT, MRI, molecular imaging, and breast imaging demand. Downstate markets provide opportunities for mobile equipment and regional system standardization.

Ohio represented approximately USD 0.46 billion. Cleveland, Columbus, and Cincinnati have major clinical programs and hospital systems with significant imaging capacity. Ohio has become especially relevant to photon-counting CT adoption following a first U.S. installation of a newly introduced system in 2025.

Michigan generated approximately USD 0.37 billion, supported by large health systems and demand across oncology, cardiovascular, neurological, and musculoskeletal imaging. Minnesota is strategically important because of its medtech ecosystem, academic providers, and expertise in advanced clinical technology.

Indiana, Wisconsin, and Missouri offer stable replacement and expansion opportunities. Indianapolis, Milwaukee, Madison, St. Louis, and Kansas City serve as important referral hubs. Iowa, Kansas, Nebraska, North Dakota, and South Dakota have smaller markets but strong requirements for distributed access, mobile imaging, and remote support.

The Midwest is expected to grow more slowly than the South and West, but it remains a durable market. Vendors that combine competitive lifecycle cost, reliable service, clinical education, and multi-site contracting will be well positioned.

Key Market Players

The U.S. Advanced Diagnostic Imaging Equipment Competitive Landscape is concentrated among a small number of broad-platform manufacturers, followed by specialized companies in breast imaging, ultrasound, molecular imaging, mobile equipment, detector technologies, and modality-specific systems.

Competition is increasingly ecosystem-based. Large manufacturers can bundle CT, MRI, PET, SPECT, ultrasound, X-ray, fluoroscopy, enterprise software, service, and financing. Specialized companies compete through differentiated performance, lower installation complexity, portability, targeted clinical applications, or more flexible commercial models.

Some of the key players in the U.S. Advanced Diagnostic Imaging Equipment industry are:

GE HealthCare
Siemens Healthineers
Philips
Canon Medical Systems USA
United Imaging Healthcare
FUJIFILM Healthcare Americas
Hologic
Samsung Medison
Samsung NeuroLogica
Shimadzu Medical Systems USA
Carestream Health
Agfa Radiology Solutions
Konica Minolta Healthcare Americas
Esaote North America
Mindray North America
Bruker
Mediso USA
Spectrum Dynamics Medical
Positron Corporation
CurveBeam AI
Planmed
Ziehm Imaging
Bayer Radiology
Bracco Diagnostics
Varex Imaging

GE HealthCare, Siemens Healthineers, Philips, Canon Medical Systems, United Imaging, and FUJIFILM form the leading broad-platform competitive group. Their advantages include installed-base scale, modality breadth, service coverage, clinical applications, financing capability, software integration, and enterprise contracting.

Hologic has a particularly strong position in breast imaging. Samsung Medison, Mindray, Esaote, and Konica Minolta compete across ultrasound and selected imaging categories. NeuroLogica, CurveBeam AI, Planmed, and Ziehm Imaging address mobile, specialty, extremity, and procedural imaging requirements.

Mediso, Spectrum Dynamics, Positron, and Bruker participate in molecular, preclinical, and specialty imaging. Bayer and Bracco contribute through contrast-delivery and injector equipment that forms part of advanced CT, MRI, and interventional imaging workflows. Varex Imaging supplies critical detector and X-ray component technologies across the equipment ecosystem.

Future market share will be influenced by FDA clearances, scanner uptime, service response, AI integration, cybersecurity, energy efficiency, evidence generation, supply-chain resilience, financing, and the ability to upgrade equipment without full replacement.

Recent Developments

Recent developments demonstrate that the market is entering a new technology cycle. In 2024, a whole-body 5T MRI platform received U.S. regulatory clearance, expanding the commercial possibilities for ultra-high-field MRI outside traditional research-limited applications.

Helium-efficient MRI also moved further into the mainstream. One manufacturer reported more than 1,100 installations of its sealed-magnet platform by May 2024 and more than 1,500 installations by early 2025. This reflects hospital interest in reducing helium exposure, installation complexity, operational risk, and long-term magnet-service requirements.

In March 2025, a broader class of photon-counting CT systems received U.S. clearance. The portfolio included dual-source and single-source configurations intended to broaden access beyond the earliest premium systems. The first U.S. installation of one new configuration was completed at an Ohio health system in September 2025.

Total-body PET/CT development also accelerated. In 2025, a major equipment manufacturer announced a collaboration with a leading U.S. academic institution to advance silicon-based total-body PET/CT technology. Such systems are being designed to improve axial coverage, sensitivity, dynamic imaging, and research capability.

AI integration continued to deepen. By the end of 2025, radiology represented approximately three-quarters of all FDA-authorized AI-enabled medical devices. The commercial focus is shifting from standalone detection algorithms toward embedded reconstruction, protocol automation, quality control, workflow orchestration, and opportunistic quantification.

Regulatory expectations are evolving alongside AI adoption. Manufacturers are increasingly expected to address lifecycle management, real-world performance monitoring, cybersecurity, data drift, and controlled software modification. Hospitals are therefore examining not only initial algorithm performance but also governance, update responsibility, local validation, and post-deployment monitoring.

Remote scanning and centralized imaging command centers are expanding as health systems respond to technologist shortages. Large networks are testing operating models in which experienced personnel provide protocol and workflow support across multiple sites. The most viable models maintain clear on-site safety responsibilities while using remote expertise to improve consistency and capacity.

The competitive environment is also being shaped by portfolio consolidation. Large imaging companies are investing in cloud infrastructure, AI workspaces, enterprise imaging, and remote operations to increase their strategic position beyond scanner hardware. Equipment procurement is consequently becoming more closely linked to long-term data and workflow architecture.

Conclusion

The U.S. Advanced Diagnostic Imaging Equipment Market Size and Share is positioned to expand from USD 13.82 billion in 2025 to approximately USD 27.44 billion by 2035, supported by a CAGR of 7.10% during the forecast period.

The market’s long-term strength is grounded in the scale of U.S. imaging utilization, a population of more than 61 million adults aged 65 and older, substantial cancer and chronic disease burden, a nationwide hospital network, and a large installed base requiring replacement and modernization.

Computed tomography will remain the largest modality, while photon-counting systems will generate premium growth. MRI will benefit from faster reconstruction, helium-efficient magnets, wider bores, workflow automation, and higher-field platforms. Molecular imaging will expand through precision oncology, neurological tracers, theranostics, and total-body PET. Ultrasound and advanced breast imaging will benefit from AI guidance, portability, and outpatient adoption.

Hospitals and integrated delivery networks will remain the dominant purchasers. Their procurement decisions will increasingly be based on examinations per day, staffing efficiency, service uptime, energy and helium requirements, construction cost, cybersecurity, software-upgrade pathways, and enterprise standardization.

The South will remain the largest regional market, led by Texas and Florida. The West will record the fastest growth, supported by California, Arizona, Washington, Colorado, and Utah. The Northeast will remain the most concentrated premium and research-oriented market. The Midwest will provide stable replacement demand and an important base for advanced clinical adoption.

For manufacturers, investors, distributors, imaging-center operators, and hospital decision-makers, the primary strategic issue is not whether U.S. imaging demand will increase. The more important questions are which technology cycles will justify premium capital allocation, how quickly outpatient and mobile models will expand, and which vendors can create measurable clinical and operating value across an equipment asset’s full life.

Companies that combine differentiated hardware, embedded intelligence, reliable service, secure connectivity, remote support, flexible financing, and credible economic evidence will define the next decade of the U.S. advanced diagnostic imaging equipment industry.

TABLE OF CONTENT

1. U.S. Advanced Diagnostic Imaging Equipment Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.2.1. Equipment and Technology Included in the Study
1.2.2. Equipment, Services and Technologies Excluded from the Study
1.2.3. Historical Period, 2021–2024
1.2.4. Base Year, 2025
1.2.5. Forecast Period, 2026–2035
1.2.6. Market Measurement in US$ Billion
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Bottom-Up Installed-Base Assessment
1.3.6. Top-Down Market Triangulation
1.3.7. Equipment Replacement-Cycle Modeling
1.3.8. Average Selling Price and Configuration Analysis
1.3.9. Analytical Frameworks & Forecasting Models
1.3.10. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.4.1. New Equipment Installation Assumptions
1.4.2. Equipment Replacement and Upgrade Assumptions
1.4.3. Pricing and Inflation Assumptions
1.4.4. Hospital Capital Expenditure Assumptions
1.4.5. Technology Adoption Assumptions
1.4.6. Reimbursement and Utilization Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Diagnostic Imaging Equipment Manufacturers
1.6.2. Detector, Magnet, Tube, Transducer and Component Suppliers
1.6.3. Imaging Software, AI and Reconstruction Technology Providers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Independent Diagnostic Imaging Centers
1.6.6. Academic Medical Centers and Research Institutions
1.6.7. Specialty Clinics and Ambulatory Facilities
1.6.8. Mobile and Rural Imaging Service Providers
1.6.9. Group Purchasing Organizations and Distributors
1.6.10. Equipment Leasing and Managed-Service Providers
1.6.11. Payers, Regulators and Clinical Decision-Makers

**What this section provides:** This section defines the market boundary, equipment scope, study period, valuation methodology, forecasting assumptions and stakeholder ecosystem used to measure and validate the U.S. advanced diagnostic imaging equipment market.

2. U.S. Advanced Diagnostic Imaging Equipment Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size, 2021–2035 (US$ Billion)
2.8. CAGR Analysis, 2026–2035 (%)
2.9. Leading Modality Analysis
2.10. Fastest-Growing Modality Analysis
2.11. Leading Application Analysis
2.12. Leading End-User Analysis
2.13. Leading Regional Market Analysis
2.14. Fastest-Growing Regional Market Analysis
2.15. High-Growth Opportunity Areas
2.16. Major Investment and Procurement Themes
2.17. Key Strategic Conclusions

**What this section provides:** This section gives decision-makers a concise view of market size, growth trajectory, modality leadership, regional performance, procurement priorities, competitive intensity and high-value opportunity areas.

3. U.S. Advanced Diagnostic Imaging Equipment Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Cancer and Chronic Disease Imaging Requirements
3.1.2. Growth of the U.S. Population Aged 65 and Older
3.1.3. Expansion of CT, MRI and Molecular Imaging Procedure Volumes
3.1.4. Replacement of Aging Diagnostic Imaging Equipment
3.1.5. Hospital Imaging Department Modernization
3.1.6. Growth of Outpatient Diagnostic Imaging Centers
3.1.7. Increasing Adoption of AI-Enabled Imaging Workflows
3.1.8. Demand for Faster Scanning and Higher Patient Throughput
3.1.9. Expansion of Precision Oncology and Molecular Imaging
3.1.10. Growth of Mobile, Portable and Point-of-Care Imaging
3.1.11. Demand for Lower-Dose and Contrast-Efficient Imaging
3.1.12. Increasing Use of Enterprise Imaging Fleet Standardization
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Advanced Imaging Equipment
3.2.2. Imaging Room Construction and Installation Requirements
3.2.3. Reimbursement Pressure and Prior Authorization
3.2.4. Radiologist and Imaging Technologist Shortages
3.2.5. Equipment Maintenance and Service Contract Costs
3.2.6. Helium, Detector and X-Ray Tube Supply Constraints
3.2.7. Long Hospital Capital Approval Cycles
3.2.8. Cybersecurity and Interoperability Risks
3.2.9. Uneven Access Across Rural and Underserved Markets
3.3. Opportunities and Their Impact Analysis
3.3.1. Photon-Counting Computed Tomography Adoption
3.3.2. Spectral and Dual-Energy CT Expansion
3.3.3. Helium-Efficient and Sealed-Magnet MRI Systems
3.3.4. High-Field and Ultra-High-Field MRI Platforms
3.3.5. Digital and Total-Body PET/CT Systems
3.3.6. AI-Guided Ultrasound and Automated Acquisition
3.3.7. Advanced Breast Imaging and Tomosynthesis
3.3.8. Remote Scanning and Centralized Command Centers
3.3.9. Software-Defined Equipment Upgrade Models
3.3.10. Mobile Imaging and Rural Access Programs
3.3.11. Equipment-as-a-Service and Managed Equipment Models
3.3.12. Outpatient Imaging Network Expansion
3.4. Challenges and Their Impact Analysis
3.4.1. Demonstrating Return on Premium Capital Investment
3.4.2. Integrating Equipment Across Multi-Vendor Imaging Fleets
3.4.3. Maintaining Equipment Uptime and Service Coverage
3.4.4. Managing Rapid Hardware and Software Obsolescence
3.4.5. Validating AI Performance Across Patient Populations
3.4.6. Balancing Premium Technology with Community-Hospital Economics
3.5. Patent & Innovation Analysis, 2021–2025
3.5.1. CT Detector and Reconstruction Patent Activity
3.5.2. MRI Magnet, Coil and Acceleration Patent Activity
3.5.3. PET and SPECT Detector Patent Activity
3.5.4. Ultrasound Transducer and AI Patent Activity
3.5.5. Breast Imaging and Tomosynthesis Patent Activity
3.6. Clinical Workflow Economics Analysis
3.6.1. Examination Throughput
3.6.2. Patient Setup and Scan-Time Economics
3.6.3. Repeat-Scan and Recall Reduction
3.6.4. Technologist Productivity
3.6.5. Radiologist Reading Efficiency
3.6.6. Emergency Department and Inpatient Throughput
3.7. Hospital Capital Procurement Behavior Analysis
3.7.1. Capital Budget Approval Process
3.7.2. Value Analysis Committee Evaluation
3.7.3. Total Cost of Ownership Assessment
3.7.4. Equipment Replacement Decision Framework
3.7.5. Enterprise Fleet Standardization
3.7.6. Vendor Financing and Managed-Service Models

**What this section provides:** This section explains the clinical, demographic, technological, reimbursement, workforce and capital-procurement forces shaping equipment demand, helping clients evaluate growth opportunities and execution risks.

4. U.S. Advanced Diagnostic Imaging Equipment Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.3.1. CT Equipment Pricing Trends
4.3.2. MRI Equipment Pricing Trends
4.3.3. PET and SPECT Equipment Pricing Trends
4.3.4. Ultrasound Equipment Pricing Trends
4.3.5. X-Ray, Fluoroscopy and Breast Imaging Pricing Trends
4.4. Value Chain & Supply Chain Analysis
4.4.1. Raw Materials and Critical Components
4.4.2. Detector and Semiconductor Suppliers
4.4.3. Magnet, Gradient and Coil Suppliers
4.4.4. X-Ray Tube and Generator Suppliers
4.4.5. Transducer and Probe Suppliers
4.4.6. Original Equipment Manufacturers
4.4.7. Distributors and Channel Partners
4.4.8. Installation and Service Organizations
4.4.9. Healthcare Provider Customers
4.5. Impact of Digitalization and Connected Imaging
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. Premarket Notification Pathway
4.7.2. Premarket Approval Considerations
4.7.3. De Novo Classification
4.7.4. AI-Enabled Imaging Device Regulation
4.7.5. Software Modification and Lifecycle Management
4.7.6. Quality System and Post-Market Requirements
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Hospital Inpatient Imaging Economics
4.8.2. Hospital Outpatient Imaging Economics
4.8.3. Physician Fee Schedule Considerations
4.8.4. Independent Diagnostic Testing Facility Reimbursement
4.8.5. Prior Authorization and Medical Necessity Requirements
4.8.6. Site-of-Service Payment Differentials
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Public Health Programs
4.10.1. Cancer Screening Initiatives
4.10.2. Rural Healthcare Access Programs
4.10.3. Veterans Health Administration Imaging Investment
4.10.4. Department of Defense Imaging Procurement
4.10.5. Public Hospital and Safety-Net Funding Programs
4.11. Impact of Escalating Geopolitical Tensions
4.11.1. Semiconductor Availability
4.11.2. Rare-Earth Material Exposure
4.11.3. Magnet and Helium Supply Risks
4.11.4. International Manufacturing and Logistics Exposure
4.12. Hospital Value Analysis Committee Decision Framework
4.12.1. Clinical Performance
4.12.2. Equipment Utilization
4.12.3. Total Installed Cost
4.12.4. Service and Uptime Guarantees
4.12.5. Staffing and Workflow Impact
4.12.6. Cybersecurity and Interoperability
4.12.7. Upgradeability and Asset-Life Extension
4.12.8. Sustainability and Energy Consumption

**What this section provides:** This section gives clients a complete view of regulation, reimbursement, pricing, supply-chain exposure, technological development, environmental considerations and hospital purchasing requirements.

5. U.S. Advanced Diagnostic Imaging Equipment Market – By Modality

5.1. Overview
5.1.1. Segment Share Analysis, By Modality, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
5.1.3. Modality Growth and Attractiveness Analysis
5.2. Computed Tomography Systems
5.2.1. Conventional Multidetector CT Systems
5.2.2. Wide-Area Detector CT Systems
5.2.3. Spectral and Dual-Energy CT Systems
5.2.4. Photon-Counting CT Systems
5.2.5. Cardiac CT Systems
5.2.6. Mobile and Specialty CT Systems
5.3. Magnetic Resonance Imaging Systems
5.3.1. 1.5-Tesla MRI Systems
5.3.2. 3-Tesla MRI Systems
5.3.3. 5-Tesla and Ultra-High-Field MRI Systems
5.3.4. Open and Wide-Bore MRI Systems
5.3.5. Extremity MRI Systems
5.3.6. Low-Field and Portable MRI Systems
5.3.7. Mobile MRI Systems
5.4. Molecular Imaging Systems
5.4.1. Standalone PET Systems
5.4.2. PET/CT Systems
5.4.3. PET/MRI Systems
5.4.4. Total-Body PET/CT Systems
5.4.5. Standalone SPECT Systems
5.4.6. SPECT/CT Systems
5.4.7. Dedicated Cardiac Nuclear Imaging Systems
5.5. Advanced Ultrasound Systems
5.5.1. Premium Cart-Based Ultrasound Systems
5.5.2. Compact and Portable Ultrasound Systems
5.5.3. Handheld Ultrasound Systems
5.5.4. 3D and 4D Ultrasound Systems
5.5.5. Elastography Systems
5.5.6. Contrast-Enhanced Ultrasound Systems
5.5.7. Automated Breast Ultrasound Systems
5.5.8. AI-Guided Ultrasound Systems
5.6. Advanced X-Ray, Fluoroscopy and Breast Imaging Systems
5.6.1. Fixed Digital Radiography Systems
5.6.2. Mobile Digital Radiography Systems
5.6.3. Advanced Fluoroscopy Systems
5.6.4. Digital Mammography Systems
5.6.5. Digital Breast Tomosynthesis Systems
5.6.6. Contrast-Enhanced Mammography Systems
5.6.7. Specialty and Procedural X-Ray Systems

**What this section provides:** This section identifies the modalities and submodalities expected to generate the largest revenue contribution, strongest replacement demand and fastest technology-led growth through 2035.

6. U.S. Advanced Diagnostic Imaging Equipment Market – By Installation Type

6.1. Overview
6.1.1. Segment Share Analysis, By Installation Type, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
6.1.3. Installation Economics and Site-Readiness Analysis
6.2. Fixed Room-Based Imaging Equipment
6.2.1. New Room Installations
6.2.2. Replacement Installations
6.2.3. Major Hardware and Detector Upgrades
6.2.4. Imaging Room Renovation Projects
6.3. Mobile Cart-Based Imaging Equipment
6.3.1. Mobile Ultrasound Systems
6.3.2. Mobile Digital Radiography Systems
6.3.3. Mobile Fluoroscopy Systems
6.3.4. Compact Nuclear Imaging Systems
6.4. Portable and Handheld Imaging Equipment
6.4.1. Handheld Ultrasound
6.4.2. Portable Ultrasound
6.4.3. Portable Digital Radiography
6.4.4. Portable and Low-Field MRI
6.5. Intraoperative and Point-of-Procedure Imaging
6.5.1. Intraoperative CT
6.5.2. Intraoperative MRI
6.5.3. Mobile 3D Imaging Systems
6.5.4. Advanced C-Arm and Procedural Imaging
6.5.5. Surgical Navigation-Integrated Imaging
6.6. Trailer-Based and Shared-Service Imaging Equipment
6.6.1. Mobile MRI Trailers
6.6.2. Mobile CT Trailers
6.6.3. Mobile PET/CT Services
6.6.4. Mobile Mammography Units
6.6.5. Shared-Service and Temporary-Capacity Models

**What this section provides:** This section evaluates demand across fixed, mobile, portable, intraoperative and shared-service installations, helping clients understand site requirements, capital intensity and deployment opportunities.

7. U.S. Advanced Diagnostic Imaging Equipment Market – By Application

7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
7.1.3. Clinical Application Growth Analysis
7.2. Oncology
7.2.1. Cancer Screening and Early Detection
7.2.2. Tumor Diagnosis and Characterization
7.2.3. Cancer Staging
7.2.4. Image-Guided Biopsy and Intervention
7.2.5. Radiotherapy Planning
7.2.6. Treatment-Response Assessment
7.2.7. Recurrence and Surveillance Imaging
7.3. Cardiology and Vascular Imaging
7.3.1. Coronary CT Angiography
7.3.2. Cardiac MRI
7.3.3. Echocardiography
7.3.4. Nuclear Cardiology
7.3.5. Vascular Ultrasound
7.3.6. Peripheral and Cerebrovascular Imaging
7.4. Neurology
7.4.1. Stroke and Cerebrovascular Imaging
7.4.2. Neuro-Oncology Imaging
7.4.3. Dementia and Neurodegenerative Disease Imaging
7.4.4. Epilepsy Imaging
7.4.5. Multiple Sclerosis Imaging
7.4.6. Traumatic Brain Injury Imaging
7.4.7. Spine and Spinal Cord Imaging
7.5. Musculoskeletal and Trauma Imaging
7.5.1. Orthopedic Imaging
7.5.2. Sports Medicine Imaging
7.5.3. Fracture and Trauma Assessment
7.5.4. Spine and Joint Imaging
7.5.5. Arthritis and Degenerative Disease Imaging
7.5.6. Surgical Planning and Postoperative Assessment
7.6. Women’s Health and Other Applications
7.6.1. Breast Cancer Screening and Diagnosis
7.6.2. Obstetric Imaging
7.6.3. Gynecological Imaging
7.6.4. Abdominal and Gastrointestinal Imaging
7.6.5. Pulmonary and Thoracic Imaging
7.6.6. Urological and Renal Imaging
7.6.7. Pediatric Imaging
7.6.8. Emergency and General Diagnostic Imaging

**What this section provides:** This section helps clients understand equipment demand by clinical use case and identify applications with high procedure volumes, strong reimbursement relevance and premium imaging requirements.

8. U.S. Advanced Diagnostic Imaging Equipment Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
8.1.3. End-User Capital Spending Analysis
8.2. Hospitals and Integrated Delivery Networks
8.2.1. Large Academic and Tertiary Hospitals
8.2.2. Community Hospitals
8.2.3. Critical Access Hospitals
8.2.4. Government and Public Hospitals
8.2.5. Multi-Hospital Integrated Delivery Networks
8.3. Independent Diagnostic Imaging Centers
8.3.1. Multi-Site Imaging Networks
8.3.2. Single-Site Diagnostic Imaging Centers
8.3.3. Radiologist-Owned Imaging Centers
8.3.4. Physician-Affiliated Imaging Centers
8.4. Academic Medical Centers and Research Institutions
8.4.1. University Hospitals
8.4.2. Cancer Research Centers
8.4.3. Neuroscience Research Centers
8.4.4. Cardiovascular Research Programs
8.4.5. Preclinical and Translational Imaging Facilities
8.5. Specialty Clinics and Ambulatory Facilities
8.5.1. Oncology Centers
8.5.2. Cardiology and Vascular Clinics
8.5.3. Orthopedic and Sports Medicine Centers
8.5.4. Women’s Health and Breast Imaging Centers
8.5.5. Ambulatory Surgery Centers
8.5.6. Urgent Care and Emergency Clinics
8.6. Mobile, Rural and Community Imaging Providers
8.6.1. Mobile Imaging Service Providers
8.6.2. Rural Health Clinics
8.6.3. Community Diagnostic Programs
8.6.4. Home and Field-Based Imaging Providers
8.6.5. Military, Veterans and Federal Imaging Facilities

**What this section provides:** This section explains which healthcare settings and customer groups are expected to drive capital purchasing, equipment replacement, mobile deployment and recurring upgrade demand.

9. U.S. Advanced Diagnostic Imaging Equipment Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
9.1.3. Procurement Decision and Contracting Analysis
9.2. Direct OEM Capital Procurement
9.2.1. New Equipment Purchases
9.2.2. Replacement Equipment Purchases
9.2.3. Direct Software and Hardware Upgrades
9.2.4. OEM Service and Maintenance Contracts
9.3. Integrated Delivery Network Enterprise Contracts
9.3.1. Multi-Modality Enterprise Agreements
9.3.2. Multi-Site Fleet Standardization
9.3.3. Long-Term Service Partnerships
9.3.4. Vendor-Neutral and Multi-Vendor Fleet Models
9.4. Group Purchasing Organization Contracts
9.4.1. National GPO Contracts
9.4.2. Regional GPO Contracts
9.4.3. Aggregated Capital Purchasing Programs
9.4.4. Service and Consumable Bundling
9.5. Distributor and Value-Added Reseller Sales
9.5.1. Regional Equipment Distributors
9.5.2. Specialty Modality Distributors
9.5.3. Value-Added Technology Integrators
9.5.4. Rural and Community Market Distribution
9.6. Leasing, Managed Equipment and Shared-Service Models
9.6.1. Operating Lease
9.6.2. Capital Lease
9.6.3. Equipment-as-a-Service
9.6.4. Managed Equipment Services
9.6.5. Pay-Per-Use and Shared-Capacity Models
9.6.6. Mobile and Temporary Imaging Contracts

**What this section provides:** This section helps clients understand how imaging equipment is acquired through direct purchasing, IDN agreements, GPO contracts, distribution, leasing and managed-equipment models.

10. U.S. Advanced Diagnostic Imaging Equipment Market – By Geography

10.1. Introduction

10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Installed-Base and Replacement-Cycle Analysis
10.1.4. Regional Imaging Procedure Volume Analysis
10.1.5. Regional Hospital and Imaging Center Infrastructure Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Imaging Workforce Availability
10.1.8. Regional Technology Adoption and Capital Investment Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Imaging Equipment Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Imaging Equipment Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Imaging Equipment Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.24. Washington, D.C.

10.4.24.1. Overview
10.4.24.2. Washington, D.C. Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.24.3. Washington, D.C. Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.4.24.4. Washington, D.C. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.24.5. Washington, D.C. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.24.6. Washington, D.C. Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Imaging Equipment Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

### 10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Installation Type, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

**What this section provides:** This section delivers detailed regional, state and Washington, D.C.-level analysis, helping clients identify installed-base concentrations, replacement opportunities, imaging hubs, technology-adoption hotspots and priority commercial territories.

11. U.S. Advanced Diagnostic Imaging Equipment Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.1.1. Overall Market Share
11.1.2. CT Equipment Market Share
11.1.3. MRI Equipment Market Share
11.1.4. Molecular Imaging Equipment Market Share
11.1.5. Ultrasound Equipment Market Share
11.1.6. X-Ray and Breast Imaging Equipment Market Share
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Specialized Participants
11.2.5. Emerging Players
11.3. Competitive Benchmarking
11.3.1. Modality Portfolio Breadth
11.3.2. U.S. Installed Base
11.3.3. Service and Maintenance Capability
11.3.4. AI and Software Integration
11.3.5. Equipment Pricing and Financing
11.3.6. Hospital and IDN Contracting Strength
11.3.7. Regulatory and Product Pipeline Positioning
11.4. Company Profiles
11.4.1. GE HealthCare
11.4.2. Siemens Healthineers
11.4.3. Philips
11.4.4. Canon Medical Systems USA
11.4.5. United Imaging Healthcare
11.4.6. FUJIFILM Healthcare Americas
11.4.7. Hologic
11.4.8. Samsung Medison
11.4.9. Samsung NeuroLogica
11.4.10. Shimadzu Medical Systems USA
11.4.11. Carestream Health
11.4.12. Agfa Radiology Solutions
11.4.13. Konica Minolta Healthcare Americas
11.4.14. Esaote North America
11.4.15. Mindray North America
11.4.16. Bruker
11.4.17. Mediso USA
11.4.18. Spectrum Dynamics Medical
11.4.19. Positron Corporation
11.4.20. CurveBeam AI
11.4.21. Planmed
11.4.22. Ziehm Imaging
11.4.23. Bayer Radiology
11.4.24. Bracco Diagnostics
11.4.25. Varex Imaging

**Note:** Each company profile will include company overview, advanced diagnostic imaging equipment portfolio, modality positioning, U.S. commercial strategy, financial positioning, installed-base strategy, regulatory updates, AI and software capabilities, partnerships, acquisitions and recent developments.

**What this section provides:** This section gives clients market-share visibility, competitor benchmarking, portfolio positioning, installed-base intelligence, innovation direction and strategic analysis of major imaging-equipment companies.

12. U.S. Advanced Diagnostic Imaging Equipment Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Photon-Counting CT
12.2.2. Spectral and Dual-Energy CT
12.2.3. Helium-Efficient MRI
12.2.4. High-Field and Ultra-High-Field MRI
12.2.5. Digital and Total-Body PET/CT
12.2.6. AI-Guided Ultrasound
12.2.7. Advanced Breast Imaging
12.2.8. Portable and Mobile Imaging
12.2.9. Remote Scanning and Command Centers
12.2.10. Software-Defined Imaging Equipment
12.3. Emerging Business Trends
12.3.1. Equipment-as-a-Service
12.3.2. Managed Equipment Services
12.3.3. Enterprise Imaging Fleet Standardization
12.3.4. Multi-Modality Procurement Contracts
12.3.5. Remote Equipment Monitoring
12.3.6. Sustainability-Based Capital Procurement
12.3.7. Outpatient and Community Imaging Expansion
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.5.1. Modality Attractiveness
12.5.2. Application Attractiveness
12.5.3. End-User Attractiveness
12.5.4. Regional Attractiveness
12.5.5. Technology Readiness
12.6. Market Entry and Expansion Scenarios
12.7. Potential Market Disruptions Through 2035

**What this section provides:** This section prepares clients for future technology shifts, changing equipment economics, new business models, investment opportunities and alternative adoption scenarios through 2035.

13. U.S. Advanced Diagnostic Imaging Equipment Market: Strategic Recommendations

13.1. Recommendations for Diagnostic Imaging Equipment Manufacturers
13.2. Recommendations for Hospitals and Integrated Delivery Networks
13.3. Recommendations for Independent Imaging Center Operators
13.4. Recommendations for Academic Medical Centers
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for Equipment Leasing and Managed-Service Providers
13.8. Recommendations for New Entrants and Startups
13.9. Go-to-Market Strategy Considerations
13.9.1. Direct Enterprise Sales Strategy
13.9.2. Regional and Community-Hospital Strategy
13.9.3. Outpatient Imaging Center Strategy
13.9.4. Rural and Mobile Imaging Strategy
13.9.5. Academic and Research Market Strategy
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. Pricing, Financing and Contracting Recommendations
13.12. Service Network and Uptime Strategy
13.13. AI, Cybersecurity and Interoperability Strategy
13.14. Clinical Evidence and Health-Economic Strategy
13.15. Merger, Acquisition and Partnership Opportunities

**What this section provides:** This section converts market intelligence into actionable recommendations for product development, capital procurement, market entry, portfolio expansion, pricing, partnerships, investment and competitive differentiation.

14. U.S. Advanced Diagnostic Imaging Equipment Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Market Estimation Limitation
14.5. Legal Disclaimer
14.6. Third-Party Data Disclaimer
14.7. Regulatory and Reimbursement Disclaimer
14.8. Company and Competitive Intelligence Disclaimer

**What this section provides:** This section clarifies the report’s scope limitations, forecasting assumptions, legal boundaries, permitted data use and third-party information considerations.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Advanced Diagnostic Imaging Equipment Market: Market Definition and Scope
TABLE 3: U.S. Advanced Diagnostic Imaging Equipment Market: Research Methodology Framework
TABLE 4: U.S. Advanced Diagnostic Imaging Equipment Market: Key Assumptions
TABLE 5: U.S. Advanced Diagnostic Imaging Equipment Market: Market Ecosystem Overview
TABLE 6: U.S. Advanced Diagnostic Imaging Equipment Market: Stakeholder Analysis
TABLE 7: U.S. Advanced Diagnostic Imaging Equipment Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Advanced Diagnostic Imaging Equipment Market: Analyst Viewpoint Summary
TABLE 9: U.S. Advanced Diagnostic Imaging Equipment Market: Market Attractiveness Index
TABLE 10: U.S. Advanced Diagnostic Imaging Equipment Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Advanced Diagnostic Imaging Equipment Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Advanced Diagnostic Imaging Equipment Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Advanced Diagnostic Imaging Equipment Market: Drivers; Impact Analysis
TABLE 14: U.S. Advanced Diagnostic Imaging Equipment Market: Restraints; Impact Analysis
TABLE 15: U.S. Advanced Diagnostic Imaging Equipment Market: Opportunities; Impact Analysis
TABLE 16: U.S. Advanced Diagnostic Imaging Equipment Market: Challenges; Impact Analysis
TABLE 17: U.S. Advanced Diagnostic Imaging Equipment Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Advanced Diagnostic Imaging Equipment Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Advanced Diagnostic Imaging Equipment Market: Hospital Capital Procurement Behavior Matrix
TABLE 20: U.S. Advanced Diagnostic Imaging Equipment Market: PESTEL Analysis
TABLE 21: U.S. Advanced Diagnostic Imaging Equipment Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Advanced Diagnostic Imaging Equipment Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Advanced Diagnostic Imaging Equipment Market: Value Chain Analysis
TABLE 24: U.S. Advanced Diagnostic Imaging Equipment Market: Supply Chain Analysis
TABLE 25: U.S. Advanced Diagnostic Imaging Equipment Market: Digitalization and Connected Imaging Impact
TABLE 26: U.S. Advanced Diagnostic Imaging Equipment Market: Application & Innovation Landscape
TABLE 27: U.S. Advanced Diagnostic Imaging Equipment Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Advanced Diagnostic Imaging Equipment Market: CMS Reimbursement and Coverage Landscape
TABLE 29: U.S. Advanced Diagnostic Imaging Equipment Market: Import/Export Restrictions & Tariff Impact
TABLE 30: U.S. Advanced Diagnostic Imaging Equipment Market: Government Initiatives and Public Health Programs
TABLE 31: U.S. Advanced Diagnostic Imaging Equipment Market: Impact of Escalating Geopolitical Tensions
TABLE 32: U.S. Advanced Diagnostic Imaging Equipment Market: Hospital Value Analysis Committee Decision Framework
TABLE 33: U.S. Advanced Diagnostic Imaging Equipment Market: Modality Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Modality
TABLE 35: U.S. Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 36: U.S. Advanced Diagnostic Imaging Equipment Market: Segment Share Analysis, by Modality, 2025 & 2035 (%)
TABLE 37: U.S. Advanced Diagnostic Imaging Equipment Market: Computed Tomography Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Advanced Diagnostic Imaging Equipment Market: Magnetic Resonance Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Advanced Diagnostic Imaging Equipment Market: Molecular Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Advanced Diagnostic Imaging Equipment Market: Advanced Ultrasound Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Advanced Diagnostic Imaging Equipment Market: Advanced X-Ray, Fluoroscopy and Breast Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Advanced Diagnostic Imaging Equipment Market: Installation Type Snapshot, 2025
TABLE 43: Segment Dashboard; Definition and Scope, by Installation Type
TABLE 44: U.S. Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 45: U.S. Advanced Diagnostic Imaging Equipment Market: Segment Share Analysis, by Installation Type, 2025 & 2035 (%)
TABLE 46: U.S. Advanced Diagnostic Imaging Equipment Market: Fixed Room-Based Imaging Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Advanced Diagnostic Imaging Equipment Market: Mobile Cart-Based Imaging Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Advanced Diagnostic Imaging Equipment Market: Portable and Handheld Imaging Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Advanced Diagnostic Imaging Equipment Market: Intraoperative and Point-of-Procedure Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Advanced Diagnostic Imaging Equipment Market: Trailer-Based and Shared-Service Imaging Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Advanced Diagnostic Imaging Equipment Market: Application Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by Application
TABLE 53: U.S. Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 54: U.S. Advanced Diagnostic Imaging Equipment Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 55: U.S. Advanced Diagnostic Imaging Equipment Market: Oncology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Advanced Diagnostic Imaging Equipment Market: Cardiology and Vascular Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Advanced Diagnostic Imaging Equipment Market: Neurology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Advanced Diagnostic Imaging Equipment Market: Musculoskeletal and Trauma Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Advanced Diagnostic Imaging Equipment Market: Women’s Health and Other Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Advanced Diagnostic Imaging Equipment Market: End User Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by End User
TABLE 62: U.S. Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 63: U.S. Advanced Diagnostic Imaging Equipment Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 64: U.S. Advanced Diagnostic Imaging Equipment Market: Hospitals and Integrated Delivery Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Advanced Diagnostic Imaging Equipment Market: Independent Diagnostic Imaging Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Advanced Diagnostic Imaging Equipment Market: Academic Medical Centers and Research Institutions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Advanced Diagnostic Imaging Equipment Market: Specialty Clinics and Ambulatory Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Advanced Diagnostic Imaging Equipment Market: Mobile, Rural and Community Imaging Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Advanced Diagnostic Imaging Equipment Market: Procurement Channel Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 71: U.S. Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 72: U.S. Advanced Diagnostic Imaging Equipment Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 73: U.S. Advanced Diagnostic Imaging Equipment Market: Direct OEM Capital Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Advanced Diagnostic Imaging Equipment Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Advanced Diagnostic Imaging Equipment Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Advanced Diagnostic Imaging Equipment Market: Distributor and Value-Added Reseller Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Advanced Diagnostic Imaging Equipment Market: Leasing, Managed Equipment and Shared-Service Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Advanced Diagnostic Imaging Equipment Market: Regional Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Region
TABLE 80: U.S. Advanced Diagnostic Imaging Equipment Market, by Region, 2021–2035 (US$ Billion)
TABLE 81: U.S. Advanced Diagnostic Imaging Equipment Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 82: West Region U.S. Advanced Diagnostic Imaging Equipment Market: Regional Overview and Trends
TABLE 83: West Region U.S. Advanced Diagnostic Imaging Equipment Market: Key Manufacturers and Procurement Ecosystem
TABLE 84: West Region U.S. Advanced Diagnostic Imaging Equipment Market, by State, 2021–2035 (US$ Billion)
TABLE 85: West Region U.S. Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 88: West Region U.S. Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 90: California Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 91: California Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 92: California Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 93: California Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 94: California Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 95: Washington Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 96: Washington Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 97: Washington Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 98: Washington Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 99: Washington Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 100: Arizona Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 101: Arizona Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 102: Arizona Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 103: Arizona Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 104: Arizona Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 105: Colorado Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 106: Colorado Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 107: Colorado Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 108: Colorado Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 109: Colorado Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 110: Oregon Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 111: Oregon Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 112: Oregon Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 113: Oregon Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 114: Oregon Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 115: Utah Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 116: Utah Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 117: Utah Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 118: Utah Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 119: Utah Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 120: Nevada Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 121: Nevada Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 122: Nevada Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 123: Nevada Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 124: Nevada Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 125: New Mexico Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 126: New Mexico Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 127: New Mexico Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 128: New Mexico Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 129: New Mexico Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 130: Idaho Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 131: Idaho Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 132: Idaho Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 133: Idaho Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 134: Idaho Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 135: Montana Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 136: Montana Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 137: Montana Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 138: Montana Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 139: Montana Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 140: Wyoming Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 141: Wyoming Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 142: Wyoming Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 143: Wyoming Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 144: Wyoming Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 145: Alaska Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 146: Alaska Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 147: Alaska Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 148: Alaska Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 149: Alaska Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 150: Hawaii Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 151: Hawaii Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 152: Hawaii Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 153: Hawaii Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 154: Hawaii Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 155: Northeast Region U.S. Advanced Diagnostic Imaging Equipment Market: Regional Overview and Trends
TABLE 156: Northeast Region U.S. Advanced Diagnostic Imaging Equipment Market: Key Manufacturers and Procurement Ecosystem
TABLE 157: Northeast Region U.S. Advanced Diagnostic Imaging Equipment Market, by State, 2021–2035 (US$ Billion)
TABLE 158: Northeast Region U.S. Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 159: Northeast Region U.S. Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 160: Northeast Region U.S. Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 161: Northeast Region U.S. Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Northeast Region U.S. Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 163: New York Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 164: New York Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 165: New York Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 166: New York Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 167: New York Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 168: Massachusetts Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 169: Massachusetts Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 170: Massachusetts Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 171: Massachusetts Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 172: Massachusetts Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 173: New Jersey Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 174: New Jersey Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 175: New Jersey Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 176: New Jersey Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 177: New Jersey Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 178: Pennsylvania Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 179: Pennsylvania Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 180: Pennsylvania Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 181: Pennsylvania Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 182: Pennsylvania Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 183: Connecticut Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 184: Connecticut Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 185: Connecticut Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 186: Connecticut Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 187: Connecticut Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 188: Maine Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 189: Maine Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 190: Maine Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 191: Maine Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 192: Maine Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 193: Vermont Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 194: Vermont Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 195: Vermont Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 196: Vermont Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 197: Vermont Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 198: New Hampshire Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 199: New Hampshire Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 200: New Hampshire Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 201: New Hampshire Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 202: New Hampshire Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 203: Rhode Island Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 204: Rhode Island Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 205: Rhode Island Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 206: Rhode Island Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 207: Rhode Island Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 208: Delaware Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 209: Delaware Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 210: Delaware Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 211: Delaware Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 212: Delaware Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 213: South Region U.S. Advanced Diagnostic Imaging Equipment Market: Regional Overview and Trends
TABLE 214: South Region U.S. Advanced Diagnostic Imaging Equipment Market: Key Manufacturers and Procurement Ecosystem
TABLE 215: South Region U.S. Advanced Diagnostic Imaging Equipment Market, by State, 2021–2035 (US$ Billion)
TABLE 216: South Region U.S. Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 217: South Region U.S. Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 218: South Region U.S. Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 219: South Region U.S. Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 221: Texas Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 222: Texas Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 223: Texas Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 224: Texas Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 225: Texas Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 226: Florida Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 227: Florida Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 228: Florida Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 229: Florida Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 230: Florida Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 231: Georgia Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 232: Georgia Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 233: Georgia Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 234: Georgia Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 235: Georgia Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 236: North Carolina Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 237: North Carolina Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 238: North Carolina Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 239: North Carolina Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 240: North Carolina Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 241: Tennessee Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 242: Tennessee Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 243: Tennessee Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 244: Tennessee Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 245: Tennessee Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 246: South Carolina Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 247: South Carolina Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 248: South Carolina Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 249: South Carolina Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 250: South Carolina Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 251: Alabama Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 252: Alabama Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 253: Alabama Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 254: Alabama Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 255: Alabama Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 256: Mississippi Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 257: Mississippi Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 258: Mississippi Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 259: Mississippi Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 260: Mississippi Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 261: Louisiana Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 262: Louisiana Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 263: Louisiana Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 264: Louisiana Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 265: Louisiana Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 266: Arkansas Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 267: Arkansas Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 268: Arkansas Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 269: Arkansas Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 270: Arkansas Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 271: Kentucky Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 272: Kentucky Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 273: Kentucky Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 274: Kentucky Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 275: Kentucky Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 276: Oklahoma Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 277: Oklahoma Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 278: Oklahoma Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 279: Oklahoma Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 280: Oklahoma Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 281: Virginia Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 282: Virginia Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 283: Virginia Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 284: Virginia Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 285: Virginia Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 286: Maryland Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 287: Maryland Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 288: Maryland Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 289: Maryland Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 290: Maryland Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 291: West Virginia Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 292: West Virginia Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 293: West Virginia Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 294: West Virginia Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 295: West Virginia Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 296: Washington, D.C. Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 297: Washington, D.C. Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 298: Washington, D.C. Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 299: Washington, D.C. Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 300: Washington, D.C. Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 301: Midwest Region U.S. Advanced Diagnostic Imaging Equipment Market: Regional Overview and Trends
TABLE 302: Midwest Region U.S. Advanced Diagnostic Imaging Equipment Market: Key Manufacturers and Procurement Ecosystem
TABLE 303: Midwest Region U.S. Advanced Diagnostic Imaging Equipment Market, by State, 2021–2035 (US$ Billion)
TABLE 304: Midwest Region U.S. Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 305: Midwest Region U.S. Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 306: Midwest Region U.S. Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 307: Midwest Region U.S. Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 309: Illinois Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 310: Illinois Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 311: Illinois Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 312: Illinois Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 313: Illinois Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 314: Ohio Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 315: Ohio Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 316: Ohio Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 317: Ohio Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 318: Ohio Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 319: Michigan Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 320: Michigan Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 321: Michigan Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 322: Michigan Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 323: Michigan Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 324: Minnesota Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 325: Minnesota Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 326: Minnesota Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 327: Minnesota Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 328: Minnesota Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 329: Indiana Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 330: Indiana Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 331: Indiana Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 332: Indiana Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 333: Indiana Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 334: Wisconsin Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 335: Wisconsin Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 336: Wisconsin Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 337: Wisconsin Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 339: Missouri Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 340: Missouri Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 341: Missouri Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 342: Missouri Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 343: Missouri Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 344: Iowa Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 345: Iowa Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 346: Iowa Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 347: Iowa Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 348: Iowa Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 349: Kansas Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 350: Kansas Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 351: Kansas Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 352: Kansas Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 353: Kansas Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 354: Nebraska Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 355: Nebraska Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 356: Nebraska Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 357: Nebraska Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 358: Nebraska Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 359: North Dakota Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 360: North Dakota Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 361: North Dakota Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 362: North Dakota Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 363: North Dakota Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 364: South Dakota Advanced Diagnostic Imaging Equipment Market, by Modality, 2021–2035 (US$ Billion)
TABLE 365: South Dakota Advanced Diagnostic Imaging Equipment Market, by Installation Type, 2021–2035 (US$ Billion)
TABLE 366: South Dakota Advanced Diagnostic Imaging Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 367: South Dakota Advanced Diagnostic Imaging Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 368: South Dakota Advanced Diagnostic Imaging Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 369: U.S. Advanced Diagnostic Imaging Equipment Market: Competitive Landscape Snapshot, 2025
TABLE 370: U.S. Advanced Diagnostic Imaging Equipment Market: Key Company Market Share Analysis, 2025
TABLE 371: U.S. Advanced Diagnostic Imaging Equipment Market: Company Positioning Matrix
TABLE 372: U.S. Advanced Diagnostic Imaging Equipment Market: Product Portfolio Benchmarking of Key Players
TABLE 373: U.S. Advanced Diagnostic Imaging Equipment Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 374: GE HealthCare: Company Profile
TABLE 375: Siemens Healthineers: Company Profile
TABLE 376: Philips: Company Profile
TABLE 377: Canon Medical Systems USA: Company Profile
TABLE 378: United Imaging Healthcare: Company Profile
TABLE 379: FUJIFILM Healthcare Americas: Company Profile
TABLE 380: Hologic: Company Profile
TABLE 381: Samsung Medison: Company Profile
TABLE 382: Samsung NeuroLogica: Company Profile
TABLE 383: Shimadzu Medical Systems USA: Company Profile
TABLE 384: Carestream Health: Company Profile
TABLE 385: Agfa Radiology Solutions: Company Profile
TABLE 386: Konica Minolta Healthcare Americas: Company Profile
TABLE 387: Esaote North America: Company Profile
TABLE 388: Mindray North America: Company Profile
TABLE 389: Bruker: Company Profile
TABLE 390: Mediso USA: Company Profile
TABLE 391: Spectrum Dynamics Medical: Company Profile
TABLE 392: Positron Corporation: Company Profile
TABLE 393: CurveBeam AI: Company Profile
TABLE 394: Planmed: Company Profile
TABLE 395: Ziehm Imaging: Company Profile
TABLE 396: Bayer Radiology: Company Profile
TABLE 397: Bracco Diagnostics: Company Profile
TABLE 398: Varex Imaging: Company Profile
TABLE 399: U.S. Advanced Diagnostic Imaging Equipment Market: Future Market Scenario Analysis, 2026–2035
TABLE 400: U.S. Advanced Diagnostic Imaging Equipment Market: Disruptive Technologies Impact Matrix
TABLE 401: U.S. Advanced Diagnostic Imaging Equipment Market: Emerging Business Trends
TABLE 402: U.S. Advanced Diagnostic Imaging Equipment Market: Business Opportunities for Startups and Existing Players
TABLE 403: U.S. Advanced Diagnostic Imaging Equipment Market: Investment Prioritization Matrix
TABLE 404: U.S. Advanced Diagnostic Imaging Equipment Market: Strategic Recommendations for Equipment Manufacturers
TABLE 405: U.S. Advanced Diagnostic Imaging Equipment Market: Strategic Recommendations for Hospitals and Integrated Delivery Networks
TABLE 406: U.S. Advanced Diagnostic Imaging Equipment Market: Strategic Recommendations for Independent Imaging Center Operators
TABLE 407: U.S. Advanced Diagnostic Imaging Equipment Market: Strategic Recommendations for Academic Medical Centers
TABLE 408: U.S. Advanced Diagnostic Imaging Equipment Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 409: U.S. Advanced Diagnostic Imaging Equipment Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 410: U.S. Advanced Diagnostic Imaging Equipment Market: Strategic Recommendations for Equipment Leasing and Managed-Service Providers
TABLE 411: U.S. Advanced Diagnostic Imaging Equipment Market: Strategic Recommendations for New Entrants and Startups
TABLE 412: U.S. Advanced Diagnostic Imaging Equipment Market: Go-to-Market Strategy Considerations
TABLE 413: U.S. Advanced Diagnostic Imaging Equipment Market: Product Positioning and Portfolio Expansion Guidance
TABLE 414: U.S. Advanced Diagnostic Imaging Equipment Market: Pricing, Financing and Contracting Recommendations
TABLE 415: U.S. Advanced Diagnostic Imaging Equipment Market: Service Network and Uptime Strategy
TABLE 416: U.S. Advanced Diagnostic Imaging Equipment Market: AI, Cybersecurity and Interoperability Strategy
TABLE 417: U.S. Advanced Diagnostic Imaging Equipment Market: Clinical Evidence and Health-Economic Strategy
TABLE 418: U.S. Advanced Diagnostic Imaging Equipment Market: Merger, Acquisition and Partnership Opportunities
TABLE 419: U.S. Advanced Diagnostic Imaging Equipment Market: Scope Limitation
TABLE 420: U.S. Advanced Diagnostic Imaging Equipment Market: Data Use Limitation
TABLE 421: U.S. Advanced Diagnostic Imaging Equipment Market: Forecasting Limitation
TABLE 422: U.S. Advanced Diagnostic Imaging Equipment Market: Market Estimation Limitation
TABLE 423: U.S. Advanced Diagnostic Imaging Equipment Market: Legal Disclaimer
TABLE 424: U.S. Advanced Diagnostic Imaging Equipment Market: Third-Party Data Disclaimer
TABLE 425: U.S. Advanced Diagnostic Imaging Equipment Market: Regulatory and Reimbursement Disclaimer
TABLE 426: U.S. Advanced Diagnostic Imaging Equipment Market: Company and Competitive Intelligence Disclaimer

List of Figures

FIGURE 1: U.S. Advanced Diagnostic Imaging Equipment Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: U.S. Advanced Diagnostic Imaging Equipment Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Advanced Diagnostic Imaging Equipment Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Modality Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Modality Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: Computed Tomography Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Magnetic Resonance Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Molecular Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Advanced Ultrasound Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Advanced X-Ray, Fluoroscopy and Breast Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Installation Type Segment Market Share Analysis, 2025 & 2035
FIGURE 23: Installation Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Fixed Room-Based Imaging Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Mobile Cart-Based Imaging Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Portable and Handheld Imaging Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Intraoperative and Point-of-Procedure Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Trailer-Based and Shared-Service Imaging Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 30: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Oncology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Cardiology and Vascular Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Neurology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Musculoskeletal and Trauma Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Women’s Health and Other Applications Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 37: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Hospitals and Integrated Delivery Networks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Independent Diagnostic Imaging Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Academic Medical Centers and Research Institutions Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Specialty Clinics and Ambulatory Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Mobile, Rural and Community Imaging Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Direct OEM Capital Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Distributor and Value-Added Reseller Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Leasing, Managed Equipment and Shared-Service Models Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: West Region U.S. Advanced Diagnostic Imaging Equipment Market Share and Leading Players, 2025
FIGURE 53: West Region Market Share Analysis by State, 2025
FIGURE 54: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: California Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Washington Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Arizona Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Colorado Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Oregon Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Utah Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Nevada Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: New Mexico Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Idaho Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Montana Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Wyoming Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Alaska Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Hawaii Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Northeast Region U.S. Advanced Diagnostic Imaging Equipment Market Share and Leading Players, 2025
FIGURE 69: Northeast Region Market Share Analysis by State, 2025
FIGURE 70: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New York Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Massachusetts Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New Jersey Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Pennsylvania Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Connecticut Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Maine Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Vermont Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New Hampshire Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Rhode Island Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Delaware Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: South Region U.S. Advanced Diagnostic Imaging Equipment Market Share and Leading Players, 2025
FIGURE 82: South Region Market Share Analysis by State, 2025
FIGURE 83: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Texas Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Florida Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Georgia Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: North Carolina Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Tennessee Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: South Carolina Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Alabama Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Mississippi Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Louisiana Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Arkansas Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Kentucky Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Oklahoma Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Virginia Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Maryland Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: West Virginia Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Washington, D.C. Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Midwest Region U.S. Advanced Diagnostic Imaging Equipment Market Share and Leading Players, 2025
FIGURE 101: Midwest Region Market Share Analysis by State, 2025
FIGURE 102: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Illinois Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Ohio Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Michigan Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Minnesota Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Indiana Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Wisconsin Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Missouri Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Iowa Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Kansas Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Nebraska Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: North Dakota Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: South Dakota Advanced Diagnostic Imaging Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 116: Company Positioning Matrix
FIGURE 117: Key Player Product Portfolio Benchmarking
FIGURE 118: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 119: Advanced Diagnostic Imaging Equipment Innovation Roadmap
FIGURE 120: Photon-Counting CT Adoption Roadmap
FIGURE 121: Helium-Efficient MRI Technology Opportunity Map
FIGURE 122: Digital and Total-Body PET/CT Growth Roadmap
FIGURE 123: Remote Scanning and Imaging Command Center Roadmap
FIGURE 124: Future Market Scenario Analysis, 2026–2035
FIGURE 125: Disruptive Technologies Impact Matrix
FIGURE 126: Emerging Business Trends Matrix
FIGURE 127: Investment Prioritization Matrix
FIGURE 128: Strategic Growth Roadmap for U.S. Advanced Diagnostic Imaging Equipment Companies
FIGURE 129: Go-to-Market Strategy Framework
FIGURE 130: Product Positioning and Portfolio Expansion Framework
FIGURE 131: Hospital Capital Procurement and Total Cost of Ownership Framework
FIGURE 132: Report Scope and Disclaimer Framework